Written Questions
Written parliamentary questions and answers between MPs and government departments.
203,640 questions
Sodium Valproate and Surgical Mesh Implants: Compensation
To ask His Majesty's Government whether they plan to produce a timetable for agreeing compensation for those harmed by pelvic mesh and the medicine valproate, as recommended in the report from the Patient Safety Commissioner, The Hughes Report: Options fo
Orphan Drugs
To ask His Majesty's Government what assessment they have made of the finding from the report by the European Federation of Pharmaceutical Industries and Associations, Patients W.A.I.T. Indicator 2024 Survey, published in May 2025, that only 50 per cent o
Medical Treatments
To ask His Majesty's Government what assessment they have made of the number of National Institute for Health and Care Excellence technology appraisals that have been terminated in the last five years; and what proportion of those terminations were rare d
Housing: Valuation
To ask His Majesty's Government, further to the Written Answer by the Parliamentary Under-Secretary of State for Communities and Local Government on 26 October 2009 (HC col 140W), on housing valuation, how many and what proportion of dwellings in (1) Wale
Business Rates
To ask His Majesty's Government, with reference to the Core Spending Power table: final local government finance settlement 2026–27 to 2028–29, published on 9 February, and the associated council tax requirement estimates for each year from 2024–25 to 202
Business Rates: Valuation
To ask His Majesty's Government for what reason the Valuation Office Agency published official statistics for the combination of Rateable Values in special category codes broken down by local authority for the 2023 Rating List, but has not published combi
Rents: Appeals
To ask His Majesty's Government whether they plan to collect data on the average time for the First-tier Tribunal (Property Chamber) to consider, process and rule upon rent appeal cases.
Innovative Medicines Fund
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 4 March (HL14721), what proportion of the Innovative Medicines Fund budget has been spent on medicines made available through managed access agreements.
Innovative Medicines Fund
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 4 March (HL14721) indicating a substantial underspend in the Innovative Medicines Fund, what steps they are taking to expand managed access pathways for innovative medici
Maternity Services
To ask His Majesty's Government what assessment they have made of the Learning Maternity System programme developed by Mykos.
Children: Reading
To ask His Majesty's Government what steps they are taking to promote reading and the use of libraries to improve reading rates among children.
Legislative Process: Costs
To ask His Majesty's Government what is the average cost of (1) drafting a Government bill, and (2) its passage through Parliament.
Undocumented Migrants
To ask His Majesty's Government how many people who entered the UK lawfully have now become overstayers and are unable to regularise their status under existing immigration rules.
Employment: Advisory Services
To ask His Majesty's Government what plans they have to enable the independent advice sector to benefit from ongoing reforms to apprenticeships, skills and employment policy.
Gender Dysphoria
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 10 March (HL14735), when they expect the national minimum dataset for adult gender dysphoria clinics to be completed and in use.
Gender Dysphoria
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 10 March (HL14740), how the Cass Review recommendations will be implemented and monitored across NHS children and young people gender services.
Gender Dysphoria
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 10 March (HL14737), when they plan to implement each of the immediate priorities for improving adult gender services in that answer.
Gender Dysphoria
To ask His Majesty's Government, with regard to the consultation report on the NHS Children and Young People’s Gender Services service specification, published on 1 April, what potential partner organisations they are considering to provide the follow thr
Gender Dysphoria
To ask His Majesty's Government, with regard to the service specification for NHS children and young people's gender services, published on 1 April, whether the NHS and relevant service providers plan to use the ICF-11 definition of gender incongruence in
Clinical Trials
To ask His Majesty's Government what assessment they have made of progress toward the target set in the Life Sciences Sector Plan, published on 16 July 2025, to reduce clinical trial set-up time to 150 days by March 2026.
Advanced Therapy Medicinal Products: Clinical Trials
To ask His Majesty's Government what steps they are taking to ensure that the United Kingdom remains internationally competitive in attracting cell and gene therapy trials, including CAR-T; and to ensure that patients can access innovative treatments with
Advanced Therapy Medicinal Products: Clinical Trials
To ask His Majesty's Government what steps they are taking to ensure that advanced therapy medicinal product clinical trials in the United Kingdom reflect the diversity of patient populations who might benefit from those treatments.
Lebanon: Palladium Group
To ask His Majesty's Government what role the company Palladium International Ltd plays in delivering UK-funded programmes in Lebanon.
Lebanon: Hezbollah
To ask His Majesty's Government what UK programmes were used to provide funding to the government of Lebanon or the Lebanese armed forces to support the dismantling of Hezbollah in the financial year 2025/26.
Lebanon: Food Aid
To ask His Majesty's Government, regarding the UK-funded World Food Programme cash assistance for conflict-affected Lebanese, (1) in which areas of Lebanon is the assistance is being delivered, (2) which organisations are acting as implementing partners a